Quest PharmaTech Inc Stock Toronto S.E.
Equities
QPT
CA74836M1068
Biotechnology & Medical Research
Sales 2023 | - | Sales 2024 | - | Capitalization | 4.23M 5.79M |
---|---|---|---|---|---|
Net income 2023 | -7M -9.58M | Net income 2024 | -3M -4.11M | EV / Sales 2023 | - |
Net Debt 2023 | 625K 856K | Net Debt 2024 | 283K 388K | EV / Sales 2024 | - |
P/E ratio 2023 |
-1.61
x | P/E ratio 2024 |
-1.4
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 82.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 04-06-16 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 04-06-16 | |
J. Lievonen
CHM | Chairman | - | 21-07-04 |
Jeffrey Shon
BRD | Director/Board Member | - | 21-07-04 |
1st Jan change | Capi. | |
---|---|---|
+23.87% | 47.96B | |
+0.41% | 42.45B | |
+43.96% | 41.47B | |
+25.77% | 31.6B | |
+20.63% | 28.63B | |
-4.47% | 28.03B | |
+51.54% | 14.56B | |
+44.43% | 14.14B | |
+1.96% | 12.58B |